Related content

C1-inhibitor therapy for hereditary angioedema attacks: Prospective patient assessments of health-related quality of life

By Bewtra Againdra K.   Levy Robyn J.   Jacobson Kraig W.   Wasserman Richard L.   Machnig Thomas   Craig Timothy J.  

Allergy and Asthma Proceedings, Vol. 33, Iss. 5, 2012-09 ,pp. : 427-431

OceanSide Publications, Inc

Access to resources Recommend Favorite

Perioperative management for patients with hereditary angioedema

By Williams Anesu H.   Craig Timothy J.  

Allergy & Rhinology, Vol. 6, Iss. 1, 2015-01 ,pp. : e50-e55

OceanSide Publications, Inc

Access to resources Recommend Favorite

The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression

By Lumry William R.   Castaldo Anthony J.   Vernon Margaret K.   Blaustein Marc B.   Wilson David A.   Horn Patrick T.  

Allergy and Asthma Proceedings, Vol. 31, Iss. 5, 2010-09 ,pp. : 407-414

OceanSide Publications, Inc

Access to resources Recommend Favorite

Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks

By Prematta Michael J.   Kemp John G.   Gibbs Joshua G.   Mende Cathy   Rhoads Crystal   Craig Timothy J.  

Allergy and Asthma Proceedings, Vol. 30, Iss. 5, 2009-09 ,pp. : 506-511

OceanSide Publications, Inc

Access to resources Recommend Favorite

Ecallantide for treatment of acute hereditary angioedema attacks: Analysis of efficacy by patient characteristics

By MacGinnitie Andrew J.   Campion Marilyn   Stolz Leslie E.   Pullman William E.  

Allergy and Asthma Proceedings, Vol. 33, Iss. 2, 2012-03 ,pp. : 178-185

OceanSide Publications, Inc

Access to resources Recommend Favorite